Pacot C, Charmoillaux M, Goudonnet H, Truchot R C, Latruffe N
Laboratoire de Biologie Moléculaire et Cellulaire, Faculté des Sciences Mirande, Université de Bourgogne, Dijon, France.
Biochem Pharmacol. 1993 Apr 6;45(7):1437-46. doi: 10.1016/0006-2952(93)90043-v.
The effects of hypothyroidism and hyperthyroidism upon liver microsomal omega-laurate hydroxylase activity (cytochrome P450 IV A1-dependent), peroxisome proliferation marker enzyme activities and acyl CoA oxidase (AOX) expression induced by ciprofibrate (2 mg/kg/day during 8 days) were studied in the male Wistar rat so as to clarify firstly the possible involvement of thyroid hormones in the modification of peroxisomal ciprofibrate-induced enzyme activities in relation to hepatic microsomal cytochrome P450 IV A1 induction, and secondly the possible direct effect of thyroid hormones on the gene expression of specific peroxisomal enzymes. No significant change was found in the ciprofibrate-induced omega-laurate hydroxylase activity in hypothyroid rats or in rats that had received a large dose of triiodothyronine (LT3), suggesting that the thyroid hormone does not interfere with the peroxisome proliferation process through such an indirect mechanism. The induction by ciprofibrate [2-(4-(2-2dichlorocyclopropyl)phenoxyl-2methyl-propion ic acid)] of mitochondrial alpha-glycerolphosphate dehydrogenase and microsomal bilirubin UDPGT was decreased about 3-fold and 1.5-fold, respectively, while the induction of peroxisomal AOX, carnitine acetyl transferase and enoyl CoA hydratase enzyme activities was decreased by 36%, 34% and 22% in thyroidectomized animals, as compared to euthyroid animals. However, no significant changes in the quantity of peroxisomal proteins and in the AOX mRNA level were noted. The administration of large doses of LT3 to normal rats decreased the peroxisomal ciprofibrate AOX enzyme induction with a marked concomitant decrease in the AOX mRNA level. This suggests that high doses of LT3 enhance the turnover of some specific mRNAs or down regulate the peroxisome proliferator receptor. Our results also do not exclude inhibition of catabolic activity towards AOX which depends on thyroid hormone.
在雄性Wistar大鼠中研究了甲状腺功能减退和甲状腺功能亢进对肝脏微粒体ω-月桂酸羟化酶活性(细胞色素P450 IV A1依赖性)、过氧化物酶体增殖标志物酶活性以及环丙贝特(8天内每天2mg/kg)诱导的酰基辅酶A氧化酶(AOX)表达的影响,以便首先阐明甲状腺激素在过氧化物酶体环丙贝特诱导的酶活性改变中与肝脏微粒体细胞色素P450 IV A1诱导相关的可能参与情况,其次阐明甲状腺激素对特定过氧化物酶体酶基因表达的可能直接作用。甲状腺功能减退的大鼠或接受大剂量三碘甲状腺原氨酸(LT3)的大鼠中环丙贝特诱导的ω-月桂酸羟化酶活性未发现显著变化,这表明甲状腺激素不会通过这种间接机制干扰过氧化物酶体增殖过程。环丙贝特[2-(4-(2,2-二氯环丙基)苯氧基)-2-甲基丙酸]对线粒体α-甘油磷酸脱氢酶和微粒体胆红素UDPGT的诱导分别降低了约3倍和1.5倍,而与甲状腺功能正常的动物相比,甲状腺切除动物中环丙贝特诱导的过氧化物酶体AOX、肉碱乙酰转移酶和烯酰辅酶A水合酶活性分别降低了36%、34%和22%。然而,过氧化物酶体蛋白数量和AOX mRNA水平未发现显著变化。向正常大鼠施用大剂量LT3可降低环丙贝特对过氧化物酶体AOX酶的诱导,同时AOX mRNA水平显著降低。这表明高剂量LT3增强了某些特定mRNA的周转或下调了过氧化物酶体增殖物受体。我们的结果也不排除对依赖甲状腺激素的AOX分解代谢活性的抑制作用。